Setting priorities for high-cost medications in public hospitals in Australia: should the public be involved?

Publisher:
CSIRO
Publication Type:
Journal Article
Citation:
Australian Health Review, 2011, 35 (2), pp. 191 - 196
Issue Date:
2011-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2010002754OK.pdf147.78 kB
Adobe PDF
(HCMs) in public hospitals in Australia. Methods. In-depth, semi-structured interviews were conducted with 24 decision-makers (executive directors of hospitals, area health service managers, directors of hospital pharmacy departments and senior medical doctors) in a Sydney Area Health Service. Interviews were digitally recorded, transcribed verbatim, thematically content analysed and coded. Results. The majority of participants perceived that the `rationing debate needs to happen in Australia. The community at large should be encouraged to understand that healthcare resources are limited and choices need to be made. The perspectives of the public, according to participants, were considered diverse (tax payers, patients, consumers). Owing to the complexities of the healthcare system, their involvement of the public in decision-making regarding access toHCMsin public hospitals was considered limited. For participants, the role of the public was likely to be at the macro level, decidinghowmuch they were prepared to spend on healthcare.
Please use this identifier to cite or link to this item: